Literature DB >> 15642580

Usefulness of real-time three-dimensional echocardiography for reliable measurement of cardiac output in patients with ischemic or idiopathic dilated cardiomyopathy.

Sean M Fleming1, Barry Cumberledge, Christoph Kiesewetter, Gareth Parry, Antoinette Kenny.   

Abstract

The determination of stroke volume (SV) is a potentially important application of real-time 3-dimensional echocardiography (RT3DE). SV measurements by thermodilution were compared with values obtained using transthoracic RT3DE in a sequential cohort of patients who underwent assessment for potential cardiac transplantation. There was a strong correlation between echocardiographically derived SV and catheterization data (r = 0.95, n = 14). On average, RT3DE appeared to underestimate SV by 7.5 ml (SD = 5.8) or 17% (SD = 12%). A role for RT3DE in the measurement of SV in severe heart failure is suggested.

Entities:  

Mesh:

Year:  2005        PMID: 15642580     DOI: 10.1016/j.amjcard.2004.08.101

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

1.  Left ventricular remodelling index (LVRI) in various pathophysiological conditions: a real-time three-dimensional echocardiographic study.

Authors:  Stefano De Castro; Stefano Caselli; Martin Maron; Antonio Pelliccia; Elena Cavarretta; Prasad Maddukuri; Domenico Cartoni; Emanuele Di Angelantonio; Jeffrey T Kuvin; Ayan R Patel; Natesa G Pandian
Journal:  Heart       Date:  2006-08-16       Impact factor: 5.994

2.  Accuracy of three-dimensional echocardiography in patients with prior anteroseptal myocardial infarction.

Authors:  Yoshiaki Maruyama; Kentaro Toyama; Shunichi Sato; Nobuyuki Masaki; Masato Kirimura; Nobuo Yoshimoto
Journal:  J Echocardiogr       Date:  2009-01-14

Review 3.  From left ventricular ejection fraction to cardiac hemodynamics: role of echocardiography in evaluating patients with heart failure.

Authors:  Donato Mele; Aurora Andrade; Paulo Bettencourt; Brenda Moura; Gabriele Pestelli; Roberto Ferrari
Journal:  Heart Fail Rev       Date:  2020-03       Impact factor: 4.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.